 Immunogenicity subcutaneous versus intramuscular Oka/Merck varicella vaccination healthy children immunogenicity safety varicella vaccine subcutaneous intramuscular injection healthy children months years old prior history varicella pediatric practices mL single lot varicella vaccine Sera day weeks postvaccination varicella antibody gpELISA Parents clinical events weeks vaccination evaluable children mean prevaccination titer gpELISA units groups Sixty-three varicella vaccine subcutaneous route immunized Postvaccination geometric mean titer subcutaneous group gpELISA units geometric mean titer intramuscular group Varicella vaccine route groups reactions injection site varicella-like rash varicella vaccine results study inadvertent intramuscular administration varicella vaccine reason revaccination